Number of the records: 1
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
SYS 0145899 LBL 00000naa--2200000-a-4500 005 20250607164308.8 008 180503s2018----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng 044 $a xo $c SK 245 10
$a ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) / $c Drgona L. ... [et al.] 500 $a Clinical Microbiology and Infection, Fe. 12 (2018) 650 12
$7 sllk_us_auth*d003141 $a choroby infekčné $2 mesh 650 22
$7 sllk_us_auth*d001691 $a terapia biologická $2 mesh 650 22
$7 sllk_us_auth*d058990 $a terapia molekulárne cielená $2 mesh 650 22
$7 sllk_us_auth*d000911 $a protilátky monoklonálne $2 mesh 655 -7
$7 sllk_us_auth*d004740 $a abstrakt v angličtine $2 mesh 700 1-
$7 sllk_us_auth*p0063373 $a Drgoňa, Ľuboš $u II. Onkologická klinika LFUK a NOÚ, Bratislava $4 ant 710 2-
$7 sllk_us_auth*0012742 $a Redakcia Onkológia $4 adp 773 0-
$7 nnas $w sllk_us_cat*0144849 $t Onkológia $x 1336-8176 $d Bratislava : SOLEN, 2018 $g Roč. 13, č. 1 (2018), s. 73
Number of the records: 1